Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis

Clinica Chimica Acta

Volumn 244, Issue 1, 1996, Pages 17-33

  Bläser, Jörg ^a   Triebel, Susanne ^a   Maasjosthusmann, Ulrich ^b   Römisch, Jürgen ^c   Krahl Mateblowski, Ute ^c   Freudenberg, Wilfried ^c   Fricke, Reinhard ^b   Tschesche, Harald ^a  

^a BIELEFELD UNIVERSITY   (Germany)

^b St Josefs Stift Sendenhorst   (Germany)

^c Behringwerke AG   (Germany)

Author keywords

Metalloproteinases; Rheumatoid arthritis; Synoviorthesis; Urokinase plasminogen activator

Indexed keywords

ALPHA 2 MACROGLOBULIN; COLLAGENASE; GELATINASE B; LACTOFERRIN; MORRHUATE SODIUM; NEUTROPHIL COLLAGENASE; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIORTHESIS;

EID: 0040708902     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(95)06172-X     Document Type: Article

References (37)

1. Woolley DE, Crossley MJ, Evanson JM. Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum 1977;20:1231-1239.
2. Birkedal-Hansen N, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: A Review. Crit Rev Oral Biol Med 1993;4:197-250.
3. Armour PC, Levi S, Gold EE, Poolwe AR, Mort JS, Roughley PJ. Activation of latent collagenase by serum proteinases that interact with immobilized immunoglobulin G. Rheumatol Int 1984;4:151-155.
4. Jose PJ, Moss IK, Maini RN, Williams TJ. Measurements of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the actute inflammatory phase. Ann Rheum Dis 1990;49:747-752.
5. Webster RO, Hong SR, Johnston RB, Hensen PM. Biological effects of the human-complement fragments C5a and C5a des-Arg on neutrophil function. Immunopharmacology 1980;2:201-219.
6. Koch AE, Kunkel SL, Burrows, JC, Evenoff HL, Haines GK, Pope RM, Strieter RM. Synovial tissue macrophages as a source of the chemotactic cytokine IL-8. J Immunol 1991;147:2187-2195.
7. Brennan FM, Zachariae CO, Chantry D, Larsen CG, Turner M, Maini RN, Matsushima K, Feldmann M. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 1990;20:2141-2144.
8. Ugai K, Ziff M, Jasin HE. Interaction of polymorphonuclear leukocytes with immune complexes trapped in joint collagenous tissue. Arthritis Rheum 1979;22:353-364.
9. 2 in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80:1550-1560.
10. Kitsis E, Weissmann G. The role of the neutrophil in rheumatoid arthritis. Clin Orthop 1991;265:63-72.
11. Tschesche H, Knäuper V, Krämer S, Michaelis J, Oberhoff R, Reinke H. Latent collagenase and gelatinase from human neutrophils and their activation. Matrix Suppl 1992;1:245-258.
12. Weiss SJ, Ortiz X, Ragsdale C, Test ST. Oxidative autoactivation of latent collagenase by human neutrophils. Science 1985;227:747-749.
13. Chatham WW, Swain R, Frohsin H, Heck LW, Miller EJ, Blackburn WD. Degradation of human articular cartilage by neutrophils in synovial fluid. Arthritis Rheum 1993;36:51-58.
14. Chatham WW, Heck LW, Blackburn WD JR. Lysis of fibrilar collagens by neutrophils in synovial fluids: a role for surface-bound immunoglobulins. Arthritis Rheum 1990;33:1333-1339.
15. Abbink JJ, Kamp AM, Nuijens JH, Swaak TJ, Hack CE. Proteolytic inactivation of alpha 1-antitrypsin and alpha 1-antichymotrypsin by neutrophils in arthritic joints. Arthritis Rheum 1993;36:168-180.
16. Michaelis J, Vissers CM, Winterborn CC. Human neutrophil collagenase cleaves α1-antitrypsin. Biochem J 1990;270:809-814.
17. Knäuper V, Reinke H, Tschesche H. Inactivation of human plasma α1-proteinase inhibitor by human PMN leucocyte collagenase. FEBS Lett 1990;163:355-357.
18. Knäuper V, Triebel S, Reinke H, Tschesche H. Inactivation of human C1-inhibitor by human PMN leucocyte matrix metalloproteinases. FEBS Lett 1991;290:99-102.
19. Niculescu DP, Stancuilescu M, Negescu I, Ionescu I, Stoia I. Chemical synovectomy by sodium salt of fatty acid. Zschr Rheumaforsch 1970;29:27-29.
20. Kätner P, Plötner G, Peter A. Cytological and biochemical changes in the synovial fluid after treatment with Varicocid. Zschr Inn Med 1973;28:694-697.
21. Arnett FC, Edwrthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchel DM, Neustaad DH, Pinalls RS, Scahller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Assosiation 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1987;31:315-324.
22. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481-491.
23. Bergmann U, Michaelis J, Oberhoff R, Knäuper V, Beckmann R, Tschesche H. Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase. J Clin Chem Clin Biochem 1989;27:351-359.
24. Günther M, Hauneck HD, Van de Leur E, Bläser J, Bender S, Fischer DC, Tschesche H, Greiling H, Heinrich PC, Graeve L. Transforming growth factor β1 regulates tissue inhibitor of metalloproteinase (TIMP-1) expression in differentiated human articular chrondrocytes. Arthritis Rheum 1994;37:395-405.
25. Schettler A, Thorn H, Jockusch BM, Tschesche H. Release of proteinases from stimulated polymorphonuclear leukocytes: evidence for subclasses of the main granule types and their association with cytoskeletal components. Eur J Biochem 1991;197:197-202.
26. Okada Y, Gonoji Y, Nakanishi I, Nagase H, Hayakawa T. Immunohistochemical demonstration of collagenase and tissue inhibitor of metailoproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virchows Arch B Cell Pathol 1990;59:305-312.
27. Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH. In situ hybridisation studies of stromelysin and collagenase mesenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991;34:1076-1084.
28. McCachren SS, Haynes BF, Niedel JE. Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry. J Clin Immunol 1990;10:19-27.
29. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992;35:35-42.
30. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993;36:372-379.
31. Konttinen YT, Lindy O, Kemppinen P, Saari H, Suomalainen K, Vauhkonen M, Lindy S, Sorsa T. Collagenase reserves in polymorphonuclear neutrophil leukocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis. Matrix 1991;11:296-301.
32. Hamilton JA, Cheung D, Filonzi EL, Piccoli DS, Wojta J, Gallichio M, McGrath K, Last K. Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts. Arthritis Rheum 1992;35:1526-1534.
33. Saxne T, Lecander I, Geborek P. Plaminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorder and osteoarthritis. J Rheumatol 1993;20:91-96.
34. Heiple JM, Ossowski L. Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis. J Exp Med 1986;164:826-840.
35. Plesner T, Ploug M, Ellis V, Rønne E, Høyer-Hansen G, Wittrup M, Lindhardt Petersen T, Tscherning T, Danø K, Ebbe Hansen N. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood 1994;83:808-815.
36. Gudewicz PW, Gilboa A. Human Urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochem Biophys Res Comm 1987;147:1176-1181.
37. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EY. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987;84,9233-9237.